S100A16 and breast cancer: In particular, S100A16 has been identified as a potent biomarker in a number of cancers, such as bladder, gastric, renal cell, pancreatic, lung, and breast cancer, notably that S100A16 has been found as an indicator of poor prognosis [14, 18, 20, 34, 35].